Clinical Trials Logo

Lithiasis clinical trials

View clinical trials related to Lithiasis.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04871984 Not yet recruiting - Renal Stone Clinical Trials

Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis

LiThuHol
Start date: May 2021
Phase:
Study type: Observational [Patient Registry]

Holmium laser is the current gold standard for lithotripsy on urinary lithiasis, while Thulium is brand new. The latter has been released in July 2020 in Europe, and only in-vitro studies have been published. The aim of this study is to compare the stone free rate in ureteroscopy, for all consecutive patients treated with laser fragmentation, between both Holmium and Thulium lasers. The costs and complications will also be studied.

NCT ID: NCT04073719 Not yet recruiting - Clinical trials for Kidney Stones, Urolithiasis, Hypocitraturia

Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)

APUL
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether certain beverages can increase urinary citrate levels in healthy individuals with no history of kidney disease.

NCT ID: NCT03771365 Not yet recruiting - Surgery Clinical Trials

Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone

Start date: January 1, 2019
Phase:
Study type: Observational

Background: Standard-PCNL was considered as the first choice for ≥2 cm renal stones. Miniaturized technique Mini-PCNL has also been implicated in the past two decades. Recently, Super-mini PCNL (SMP) was introduced to treated ≤2.5cm renal stone. The miniaturized techniques seemed to take a longer operating time and have risk of getting infectious complications. However, there is no high quality of evidence showing that which kind of PCNL is best or what kind of patients is suitable for standard-PCNL, mini-PCNL or SMP. Objective: To compare the efficacy and safety of Standard-PCNL (≥24Fr), Mini-PCNL (12-20Fr) and SMP(10-14Fr) for the treatment of ≥2 cm renal stones Study design: This study is a prospective, observational, international, multicenter registry cohort study Study population: All patients ≥14 years with ≥2 cm renal stone who are planned for Standard-PCNL, Mini-PCNL or SMP are eligible for this study.